In our study, we found increased expression of the NLRP3 inflammasome in NAFLD rats, and Chaihu-Shugan-San significantly inhibited overexpression of the NLRP3 inflammasome. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.